Sign in
4

Changes in Ownership

Marker Therapeutics, Inc. Filed Acc 0001209191-22-032166

Options or other derivatives

  • Director acquired 80,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Eansor Norman David Director 2022-05-24 Grant or award · Stock Option (Right to Buy) +80,000 80,000 D
Loading xslF345X03/doc4.xml…